The multifaceted circulating endothelial cell in cancer: towards marker and target identification - PubMed (original) (raw)

Review

doi: 10.1038/nrc1971. Epub 2006 Oct 5.

Affiliations

• PMID: 17036040
• DOI: 10.1038/nrc1971

Review

The multifaceted circulating endothelial cell in cancer: towards marker and target identification

Francesco Bertolini et al. Nat Rev Cancer. 2006 Nov.

Abstract

Increases in the number of circulating endothelial cells (CECs) and progenitors (CEPs) have been reported in various pathological conditions including cancer. Preclinical studies have shown that CEC and CEP kinetics correlate well with several standard laboratory angiogenesis assays, which cannot be used in humans. At the clinical level, evidence is emerging that CEC kinetics and viability might correlate with clinical outcomes in cancer patients who undergo anti-angiogenic treatment. Therefore, CEC and CEP measurement has potential as a surrogate marker for monitoring anti-angiogenic treatment and drug activity, and could help to determine the optimal biological dose of anti-angiogenic drugs, which are being used with increasing frequency in medical oncology.

PubMed Disclaimer

Similar articles

• Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells.
  Bertolini F. Bertolini F. Cancer Metastasis Rev. 2008 Mar;27(1):95-101. doi: 10.1007/s10555-007-9110-y. Cancer Metastasis Rev. 2008. PMID: 18066648 Review.
• Circulating endothelial cells as biomarkers in clinical oncology.
  Mancuso P, Bertolini F. Mancuso P, et al. Microvasc Res. 2010 May;79(3):224-8. doi: 10.1016/j.mvr.2010.02.007. Epub 2010 Feb 20. Microvasc Res. 2010. PMID: 20176038 Review.
• Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology.
  Bertolini F. Bertolini F. Breast. 2009 Oct;18 Suppl 3:S48-50. doi: 10.1016/S0960-9776(09)70272-3. Breast. 2009. PMID: 19914542
• Molecular and cellular biomarkers for angiogenesis in clinical oncology.
  Bertolini F, Mancuso P, Shaked Y, Kerbel RS. Bertolini F, et al. Drug Discov Today. 2007 Oct;12(19-20):806-12. doi: 10.1016/j.drudis.2007.08.011. Epub 2007 Sep 27. Drug Discov Today. 2007. PMID: 17933680 Review.
• [Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy].
  Farace F, Bidart JM. Farace F, et al. Bull Cancer. 2007 Jul;94 Spec No:S254-9. Bull Cancer. 2007. PMID: 17846012 Review. French.

Cited by

• Dynamics of Endothelial Cell Diversity and Plasticity in Health and Disease.
  Larionov A, Hammer CM, Fiedler K, Filgueira L. Larionov A, et al. Cells. 2024 Jul 29;13(15):1276. doi: 10.3390/cells13151276. Cells. 2024. PMID: 39120307 Free PMC article. Review.
• PD-L1-positive circulating endothelial progenitor cells associated with immune response to PD-1 blockade in patients with head and neck squamous cell carcinoma.
  Su NW, Dai SH, Hsu K, Chang KM, Ko CC, Kao CW, Chang YF, Chen CG. Su NW, et al. Cancer Immunol Immunother. 2024 Jan 4;73(1):3. doi: 10.1007/s00262-023-03595-0. Cancer Immunol Immunother. 2024. PMID: 38175307 Free PMC article.
• Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer.
  Zhang J, Hong Y, Wang L, Hu W, Tian G, Wu D, Wang Y, Dai L, Zhang Z, Yang Y, Fang J. Zhang J, et al. Front Oncol. 2023 May 5;13:829054. doi: 10.3389/fonc.2023.829054. eCollection 2023. Front Oncol. 2023. PMID: 37213309 Free PMC article.
• The Impact of Surgery on Circulating Malignant Tumour Cells in Oral Squamous Cell Carcinoma.
  Curtin J, Thomson P, Wong G, Lam A, Choi SW. Curtin J, et al. Cancers (Basel). 2023 Jan 18;15(3):584. doi: 10.3390/cancers15030584. Cancers (Basel). 2023. PMID: 36765549 Free PMC article.
• Origin, prospective identification, and function of circulating endothelial colony-forming cells in mice and humans.
  Lin Y, Banno K, Gil CH, Myslinski J, Hato T, Shelley WC, Gao H, Xuei X, Liu Y, Basile DP, Yoshimoto M, Prasain N, Tarnawsky SP, Adams RH, Naruse K, Yoshida J, Murphy MP, Horie K, Yoder MC. Lin Y, et al. JCI Insight. 2023 Mar 8;8(5):e164781. doi: 10.1172/jci.insight.164781. JCI Insight. 2023. PMID: 36692963 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information